INS and type 2 diabetes mellitus: Vildagliptin 50 mg QD was effective when combined with insulin therapy in patients with severe renal impairment and long-term type 2 diabetes; reductions in HbA1c were similar to those previously reported among patients with recently developed type 2 diabetes with normal renal function.